Investigators sought to evaluate changes in the estimated CV risk of men with prostate cancer after 6 months of hormone therapy using clinical tools established for the general population. A post-hoc ...
Q. You recently wrote that testosterone does not increase the risk for heart attacks. But you overlooked the real risk of ...
A new long-term prediction tool estimates the risk of dying from prostate cancer, offering a more accurate way to interpret ...
Academics from the University of Bedfordshire have worked with other experts on new research into prostate cancer ...